BioCorteX

Nexilico

This company develops a computational discovery platform for precision microbiome engineering to help pharmaceutical firms and healthcare providers design targeted therapies and personalised treatments.

Anto

This company develops foundation models to predict drug toxicity and efficacy by analysing gut microbiome data for pharmaceutical firms and drug developers.

Outpost Bio

This company builds machine learning models of the human microbiome to help pharmaceutical and consumer health teams predict drug interactions and ingredient efficacy.

Meta-Flux

Meta-Flux provides a computational disease-simulation platform for pharmaceutical and biotechnology companies to improve drug discovery and preclinical development.

Anto Biosciences

This company develops foundation models for microbial communities to predict drug toxicity and efficacy for pharmaceutical and biotechnology researchers.

TrialeX

This company provides a digital platform for clinical trial recruitment and management to pharmaceutical companies, researchers, and potential participants.

Deeplife

This company develops a cellular digital twin platform using artificial intelligence and multi-omics data to accelerate drug discovery for biotechnology and pharmaceutical researchers.

Biomesense

This company develops automated biosensors and analytics software for continuous gut microbiome tracking for clinical researchers, biotechnology firms and pharmaceutical organisations.